Vera Therapeutics VERA Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's cash ratio?
- Vera Therapeutics (VERA) reported cash ratio of 2.5× in Q1 2026.
- How has Vera Therapeutics's cash ratio changed year-over-year?
- Vera Therapeutics's cash ratio increased by 0.7% year-over-year, from 2.5× to 2.5×.
- What is the long-term trend for Vera Therapeutics's cash ratio?
- Over 5 years (2020 to 2025), Vera Therapeutics's cash ratio has grown at a -21.6% compound annual growth rate (CAGR), from 22.4× to 6.6×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.